Ehab Moussa

Title: Ehab Moussa: Innovator in Pharmaceutical Formulations

Introduction

Ehab Moussa is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative approach focuses on the formulation of specific compounds that enhance therapeutic efficacy.

Latest Patents

Ehab Moussa holds 1 patent for his work titled "Pharmaceutical formulations for subcutaneous administration." This patent discloses compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which are formulated in a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through subcutaneous administration of these compositions.

Career Highlights

Throughout his career, Ehab Moussa has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Ehab has collaborated with several professionals in his field, including Matthew Rosebraugh and Feroz Jameel. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Ehab Moussa's work in pharmaceutical formulations represents a significant advancement in the treatment of Parkinson's disease. His innovative contributions continue to impact the field positively.